Cureety Acquires Reimagine Care to Enhance Precision Oncology Platforms
Cureety has completed the acquisition of Reimagine Care, merging Cureety’s specialized oncology monitoring and clinical intelligence with Reimagine Care’s AI-driven patient engagement capabilities and expert oncology care teams.
This strategic alliance creates a robust organization that serves over 250 cancer centers and supports more than 100,000 patients across five countries, employing a workforce of around 150 individuals.
The two companies aim to establish a more integrated precision oncology care model, especially as cancer treatments grow more personalized and complex, shifting care delivery beyond conventional hospital environments.
Innovative Oncology Monitoring
Cureety’s platform is tailored for oncology, featuring therapy-specific monitoring and triage intelligence. This design aids care teams in identifying potential patient deterioration, prioritizing care, and alleviating administrative burdens through streamlined digital workflows.
The platform takes into account a patient’s treatment regimen, cancer type, and unique clinical circumstances, distinguishing between expected treatment effects and changes that may necessitate clinical intervention.
AI-Enhanced Patient Engagement
Reimagine Care contributes a U.S.-focused oncology care model, utilizing its Remi AI-enabled platform that enhances patient interaction. Remi engages patients in a conversational manner, collects clinically significant information, and refers cases to human clinicians as needed.
For cancer centers and community oncology practices in the U.S., the unified platform is engineered to fit seamlessly into existing clinical workflows. It integrates therapy-specific intelligence with AI-supported patient engagement, thereby expanding oncology clinical capacity.
Supporting Complex Treatments
The integrated capabilities of Cureety and Reimagine Care are especially pertinent as advanced treatments, like CAR-T therapies and bispecific antibodies, are increasingly adopted in decentralized care settings. These settings require robust infrastructure to monitor and support patients effectively between in-person consultations.
Moreover, the companies envision enhancing clinical trials and observational studies by offering continuous, therapy-specific monitoring, safety support, and detailed longitudinal data.
24/7 Clinical Support
Reimagine Care ensures that patients have round-the-clock access to oncology-trained clinicians, reporting that its platform can address 95% of patient needs virtually. This approach significantly decreases unnecessary emergency visits and reduces the administrative load on healthcare providers.
With this acquisition, Cureety expands its footprint in both Europe and the U.S., working to create a care model that customizes monitoring, engagement, and clinical support according to each patient’s therapy, risk factors, and individual requirements.
Vision for the Future
François-Guirec Champoiseau, CEO and Co-Founder of Cureety, emphasizes the global challenge posed by cancer and the need for precise care models: “Advances in treatment are creating similar opportunities and challenges for oncology teams worldwide. By understanding the specifics of each patient’s therapy and daily condition, we can help care teams focus their expertise where it is most needed.”
In alignment with this vision, a spokesperson from Reimagine Care notes the necessity for care models to evolve alongside treatment sophistication. “Patients deserve highly personalized support, regardless of their location or timing, while ensuring oncologists remain central to their care. Our collaboration allows U.S. oncology organizations to enhance access to advanced treatments, boost clinical capacity, and maintain ongoing patient connectivity without overburdening already strained teams.”
Key Takeaways
- Cureety’s acquisition of Reimagine Care enhances oncology care through integration of AI and patient engagement.
- The alliance serves over 250 cancer centers and aims to create a continuous care model.
- The combined platform addresses the complexities of advanced cancer treatments and supports clinical trials with detailed monitoring.
In conclusion, the merger of Cureety and Reimagine Care marks a significant milestone in the evolution of precision oncology. By leveraging advanced technology and clinical expertise, this partnership aims to redefine patient engagement and care delivery in oncology, ultimately improving outcomes for patients worldwide.
Read more → pulse2.com